Parkinson’s Disease Treatment Market Share, Demand, Structure, Growth, Industry Drivers and Success Factors by 2025

This post was originally published on this site

The MarketWatch News Department was not involved in the creation of this content.

Apr 29, 2021 (SUPER MARKET RESEARCH via COMTEX) — According to IMARC Group’s report, titled “Parkinson’s Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025“, the global parkinson’s disease treatment market grew at a CAGR of around 6% during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth by 2025.

Parkinson’s disease refers to a progressive nervous system disorder that affects movements in an individual. It is characterized by the degeneration of motor neurons in the brain that leads to the development of rigidity, tremors, motor impairment, depression and dementia. Healthcare professionals are widely utilizing medications, supportive therapies and surgical procedures to manage the symptoms of the disease in an efficient manner and offer comfort to the patient during a seizure. Some of the most commonly prescribed medications include dopamine agonists, anticholinergics and carbidopa-levodopa medicines.

Request Free Sample Report:https://bit.ly/3u5iVMz

The parkinson’s disease treatment market is primarily driven by the steadily increasing number of patients suffering from Parkinson’s disease on the global level. Along with this, a considerable rise in the geriatric population that is more prone to develop neurodegenerative ailments is expected to provide a thrust to the market growth. Moreover, continual developments in gene therapy, neurostimulation tools, and neural transplantation procedures are anticipated to create a positive outlook for the market. Some of the other factors contributing to the market growth include rising awareness regarding efficient treatment options and significant improvements in the healthcare infrastructure.

Parkinson’s Disease Treatment Market Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the parkinson’s disease treatment market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • AbbVie Inc. (NYSE: ABBV)
  • Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
  • Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
  • F. Hoffmann-La Roche AG (SWX: RO)
  • Novartis AG (SWX: NOVN)
  • Orion Corporation (HEL: ORNBV)
  • Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA)
  • Teva Pharmaceutical Industries (TLV: TEVA)
  • Wockhardt Ltd. (NSE: WOCKPHARMA)
  • GlaxoSmithKline Plc (LON: GSK)
  • H. Lundbeck A/S (CPH: LUN)
  • Merck & Co. Inc. (NYSE: MRK)

The report has segmented the global parkinson’s disease treatment market on the basis of region, drug class, administration and distribution channel.

Breakup by Drug Class:

  • Carbidopa/Levodopa
  • Dopamine Receptor Agonists
  • MAO Inhibitors
  • COMT Inhibitors
  • Anticholinergics
  • Others

Breakup by Route of Administration:

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Explore Full Report with TOC & List of Figure: https://bit.ly/3300oWk

Key highlights of the report:

  • Market Performance (2014-2019)
  • Market Outlook (2020-2025)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Reports:

Polycystic Ovarian Syndrome Treatment Market

Hypoactive Sexual Desire Disorder Treatment Market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

The post Parkinson’s Disease Treatment Market Share, Demand, Structure, Growth, Industry Drivers and Success Factors by 2025 appeared first on Super Market Research.

COMTEX_385326040/2607/2021-04-29T08:01:04

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.